• Korro Bio, Inc. is trading at $14.00 (7.8% up) in after-hours trading.
  • The stock gained 17.56% during the regular session on June 18, 2026, driven by renewed investor optimism.
  • Jones Trading recently upgraded the stock from Hold to Buy with a $23.00 price target, and the company has announced promising preclinical data for its KRRO-111 program for AATD treatment.